>>Signaling Pathways>> Apoptosis>> Bcl-2 Family>>(E)-Ferulic acid

(E)-Ferulic acid

Catalog No.GC34980

(E)-Ferulic acid는 식물 세포벽에 풍부한 방향족 화합물인 Ferrulic acid의 이성질체입니다. (E)-페룰린산은 β-카테닌의 인산화를 일으켜 β-카테닌의 프로테아좀 분해를 유발하고 pro-apoptotic factor Bax의 발현을 증가시키고 pro-survivin 인자 survivin의 발현을 감소시킨다. (E)-페룰산은 활성산소종(ROS)을 제거하고 지질 과산화를 억제하는 강력한 능력을 보여줍니다. (E)-Ferulic acid는 인간 폐암 세포주 H1299에서 항증식 및 항이동 효과를 모두 발휘합니다.

Products are for research use only. Not for human use. We do not sell to patients.

(E)-Ferulic acid Chemical Structure

Cas No.: 537-98-4

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$39.00
재고 있음
100mg
US$35.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(E)-Ferulic acid is a isomer of Ferulic acid which is an aromatic compound, abundant in plant cell walls. (E)-Ferulic acid causes the phosphorylation of β-catenin, resulting in proteasomal degradation of β-catenin and increases the expression of pro-apoptotic factor Bax and decreases the expression of pro-survival factor survivin. (E)-Ferulic acid shows a potent ability to remove reactive oxygen species (ROS) and inhibits lipid peroxidation. (E)-Ferulic acid exerts both anti-proliferation and anti-migration effects in the human lung cancer cell line H1299[1]. Bax

[1]. Fong Y, et al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med. 2016 Oct 1;11:45.

리뷰

Review for (E)-Ferulic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (E)-Ferulic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.